new_0222_0473|FDMT|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0473|FDMT|Long Name|1|1|4D Molecular Therapeutics Inc Total Current Assets (Quarterly) (USD)|4D Molecular Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|4D Molecular Therapeutics Inc Inventories (Quarterly) (USD)|4D Molecular Therapeutics Inc Net PP&E (Quarterly) (USD)|4D Molecular Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Liabilities (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Deposits (Quarterly) (USD)|4D Molecular Therapeutics Inc Book Value (Quarterly) (USD)|4D Molecular Therapeutics Inc Retained Earnings (Quarterly) (USD)|4D Molecular Therapeutics Inc Treasury Stock (Quarterly) (USD)|4D Molecular Therapeutics Inc EV to Revenues|4D Molecular Therapeutics Inc EV to Earnings|4D Molecular Therapeutics Inc EV to Free Cash Flow|4D Molecular Therapeutics Inc EV to Assets (Quarterly)|4D Molecular Therapeutics Inc PS Ratio|4D Molecular Therapeutics Inc PE Ratio|4D Molecular Therapeutics Inc Price to Book Value|4D Molecular Therapeutics Inc PEG Ratio|4D Molecular Therapeutics Inc Debt to Equity Ratio|4D Molecular Therapeutics Inc Dividend Yield|4D Molecular Therapeutics Inc Shareholder Yield (TTM)|4D Molecular Therapeutics Inc Percent of Shares Outstanding Short|4D Molecular Therapeutics Inc Total Receivables (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Payables (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Capital Stock (Quarterly) (USD)|4D Molecular Therapeutics Inc Return on Invested Capital|4D Molecular Therapeutics Inc Quality Ratio Score|4D Molecular Therapeutics Inc Momentum Score|4D Molecular Therapeutics Inc Beta (1Y)|4D Molecular Therapeutics Inc Sustainable Growth Rate (TTM)|4D Molecular Therapeutics Inc Institutional Investor Ownership Percentage|4D Molecular Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|4D Molecular Therapeutics Inc Total Employees (Annual)|4D Molecular Therapeutics Inc EPS Diluted (Quarterly) (USD)|4D Molecular Therapeutics Inc Shares Outstanding|4D Molecular Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|4D Molecular Therapeutics Inc Ordinary Shares Number (Quarterly)|4D Molecular Therapeutics Inc Payout Ratio|4D Molecular Therapeutics Inc Quick Ratio (Quarterly)|4D Molecular Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|4D Molecular Therapeutics Inc Stock Buybacks (Quarterly) (USD)|4D Molecular Therapeutics Inc Effective Tax Rate (TTM)|4D Molecular Therapeutics Inc Return on Equity|4D Molecular Therapeutics Inc Net Income (TTM) (USD)|4D Molecular Therapeutics Inc Revenue (TTM) (USD)|4D Molecular Therapeutics Inc Dividend Per Share (Quarterly) (USD)|4D Molecular Therapeutics Inc Revenue (Quarterly) (USD)|4D Molecular Therapeutics Inc Gross Profit (Quarterly) (USD)|4D Molecular Therapeutics Inc SG&A Expense (Quarterly) (USD)|4D Molecular Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|4D Molecular Therapeutics Inc Net Income (Quarterly) (USD)|4D Molecular Therapeutics Inc Net Interest Income (Quarterly) (USD)|4D Molecular Therapeutics Inc Price (USD)|4D Molecular Therapeutics Inc Total Return Price (USD)|4D Molecular Therapeutics Inc Enterprise Value (USD)|4D Molecular Therapeutics Inc 30-Day Average Daily Volume|4D Molecular Therapeutics Inc 1 Year Price Returns (Daily)
new_0222_0473|FDMT|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0473|FDMT||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0473|FDMT||5|5|143.428571429|143.428571429|0|143.428571429|0|143.428571429|143.428571429|143.428571429|0|143.428571429|143.428571429|0|1.45238095238|91|1.44839857651|91|1.45238095238|0|1.45238095238|0|91.2857142857|1.45238095238|0|15.2592592593|143.428571429|143.428571429|143.428571429|91|0|0|31|91|30.4615384615|91.375|121.666666667|91.375|27.9166666667|0|143.428571429|91.4|91.2857142857|91.375|0|0|91|91.4|91.4|0|91.375|0|91.375|91.375|91.375|91.375|1.45238095238|1.45238095238|1.45238095238|1.43773584906|1.42857142857
new_0222_0473|FDMT||6|6|7|7|0|7|0|7|7|7|0|7|7|0|294|3|281|3|294|0|294|0|7|294|0|27|7|7|7|3|0|0|1|3|13|8|3|8|12|0|7|5|7|8|0|0|3|5|5|0|8|0|8|8|8|8|294|294|294|265|42
new_0222_0473|FDMT||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0473|FDMT|201812|201812|201812|94.068|91.761||2.472||124.556|8.054|116.502||-27.587|-30.026||||||||||||||1.124|0.954|0.001||||||||||||21.5956||||||||||||||||||||
new_0222_0473|FDMT|201906|201906|201906|75.445|72.869||4.026||122.804|8.603|114.201||-42.304|-46.235||||||||||||||1.161|1.296|0.001||||||||||||21.5956||||||||||||||||||||
new_0222_0473|FDMT|201909|201909|201909||||||||||||||||||||||||||||||||||14.8353||-1.124||||||-1.124|||||||0.54||3.052|-16.675|-16.675|0.341|||||
new_0222_0473|FDMT|201912|201912|201912|52.508|49.652||5.049||131.204|12.955|118.249||-72.97|-79.025||||||||||0||||0.978|1.744|0.001|||||||14.8353||-1.0863|||21.5956||3.9081|-1.0863|||||||2.03||5.959|-16.115|-16.115|0.218|||||
new_0222_0473|FDMT|202003|202003|202003||||||||||||||||||||||||||||||||||14.8353||-0.8871||||||-0.8871|||||||3.535||3.654|-13.16|-13.16|0.13|||||
new_0222_0473|FDMT|202006|202006|202006||||||||||||||||||||||||||||||||||14.8353||-1.0214||||0||-1.0214||||-61.103|9.738||3.633||3.062|-15.153|-15.153|0.014|||||
new_0222_0473|FDMT|202009|202009|202009|92.536|88.755||4.981||28.036|14.278|13.758||70.156|-115.132||||||||||0||||0.896|1.292|0.002|||||||21.5956|78|-0.3627|||21.5956|0|6.279|-0.3627||||-52.261|16.619||7.421||3.682|-7.833|-7.833|0.004|||||
new_0222_0473|FDMT|202012|202012|202012|282.656|276.726||5.073||31.944|16.744|15.2||256.387|-135.679||60.92|-14.6269|-15.9749|2.876|59.3402||4.3137||0|0||0.5961|1.486|1.787|0.003|-67.073||||-154.3238|77.0587|26.682|83|-0.7701|26.682||26.682|0|16.6156|-0.7701|||-154.3238|-56.693|13.612||-0.977||6.84|-20.547|-20.547|0.004|41.45|41.45|829.2429||
new_0222_0473|FDMT|202101|202012|202012|||||||||||||62.7038||-16.4427||60.643||4.4084|||0||0.5897|||||||||79.1862||||||||||||||||||||||42.36|42.36|853.5235|147802.1|
new_0222_0473|FDMT|202102|202012|202012|||||||||||||61.9589||-16.2474||60.099||4.3688|||0||1.7035|||||||||79.8589||||||||||||||||||||||41.98|41.98|843.3844|132970.5333|
new_0222_0473|FDMT|202103|202103|202103|264.501|259.865||5.011||27.683|13.916|13.767||242.431|-152.085||74.3676|-14.9842|-16.8405|3.325|80.6421||4.7766||0|0||2.8141|0.965|1.284|0.003|-31.6037||||-66.0558|85.0947|26.6902||-0.61|26.6944||26.6944|0|18.7432|-0.61|||-66.0558|-59.939|12.077||2||5.543|-16.406|-16.406|0.007|43.38|43.38|898.1381|200419.9667|
new_0222_0473|FDMT|202104|202103|202103|||||||||||||64.0232||-14.498||71.9421||4.2613|||0||3.1005|||||||||84.0583||||||||||||||||||||||38.7|38.7|773.2083|159227|
new_0222_0473|FDMT|202105|202103|202103|||||||||||||37.3026||-8.4472||49.3742||2.9302|||0||3.3044|||||||||83.6188||||26.7458||||||||||||||||||26.56|26.56|450.5034|117364.1667|
new_0222_0473|FDMT|202106|202106|202106|248.752|243.743||5.58||14.288|9.87|4.418||240.646|-159.674||17.5388|-7.7101|-6.3111|1.584|26.5929||2.6909||0|0||3.5223|1.218|1.962|0.003|-25.8763||||-35.5494|94.0139|26.7391|104|-0.28|26.8919||26.8919|0|24.8187|-0.28|||-35.5494|-52.375|23.024||14.58||6.953|-7.589|-7.589|0.007|24.08|24.08|403.814|157956.6667|
new_0222_0473|FDMT|202107|202106|202106|||||||||||||18.4615||-6.6431||27.4654||2.7792|||0||3.7162|||||||||95.2726||||||||||||||||||||||24.87|24.87|425.0586|150427.1333|
new_0222_0473|FDMT|202108|202106|202106|||||||||||||25.2237||-9.0763||33.7381||3.4262|||0||3.8698|||||||||95.0853||||26.9883||||||||||||||||||30.55|30.55|580.7496|98539.7333|
new_0222_0473|FDMT|202109|202109|202109|165.733|161.675||8.789||16.484|11.373|5.111||224.134|-181.913||33.6485|-8.5501|-8.237|2.373|42.5687||3.2688||0|0||5.9039|0.791|3.713|0.003|-32.3002||||-32.3002|96.1738|27.0224|121|-0.82|27.1656||27.1656|0|14.2852|-0.82|||-32.3002|-66.781|16.969||1.366||8.187|-22.239|-22.239|0.435|26.97|26.97|570.9812|206674.8333|
new_0222_0473|FDMT|202110|202109|202109|||||||||||||28.9419||-7.0848||37.9283||2.9125|||0||5.8972|||||||||||||||||||||||||||||||24.03|24.03|491.1144|248839.4|
new_0222_0473|FDMT|202111|202109|202109|||||||||||||34.0337||-8.3313||36.3026||3.298|||0||2.738|||||||||88.2706||||32.1388||||||||||||||||||23|23|577.5174|313221.6333|
new_0222_0473|FDMT|202112|202112|202112|||||||||||||32.0261||-7.8398||34.6295||3.146|||0||4.3477|||||||0.5347||93.7284||||||||||||||||||||||21.94|21.94|543.4503|359705.2667|-47.0688
new_0222_0473|FDMT|202201|202112|202112|||||||||||||20.3971||-4.9931||24.9383||2.2656|||0||4.8675||||||2|1.5805||91.711||||||||||||||||||||||15.8|15.8|346.118|327814.9667|-62.7007
new_0222_0473|FDMT|202202|202112|202112|||||||||||||18.8251||-4.6083||23.6283||2.1466|||0|||||||||||||||||||||||||||||||||14.97|14.97|319.4428|235208.5|-71.5777